Ikarian Capital, LLC Kodiak Sciences Inc. Put Options Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$5.04 - $9.48 $368,424 - $692,988	-73,100 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.09 - $89.45 $518,279 - $6.54 Million	73,100 New	73,100 $565,000
Q4 2020 Feb 12, 2021	SELL	$60.78 - $154.03 $15.2 Million - $38.5 Million	-250,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$45.05 - $59.27 $11.3 Million - $14.8 Million	250,000 New	250,000 $14.8 Million
Q2 2020 Aug 14, 2020	SELL	$42.74 - $66.25 $504,332 - $781,750	-11,800 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$38.18 - $73.95 $450,524 - $872,610	11,800 New	11,800 $563,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $288M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.